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Abstract
Background: While attempting to reanalyze published data from Agilent 4 × 44 human expression
chips, we found that some of the 60-mer olignucleotide features could not be interpreted as
representing single human genes. For example, some of the oligonucleotides align with the
transcripts of more than one gene. We decided to check the annotations for all autosomes and the
X chromosome systematically using bioinformatics methods.
Results:  Out of 42683 reporters, we found that 25505 (60%) passed all our tests and are
considered "fully valid". 9964 (23%) reporters did not have a meaningful identifier, mapped to the
wrong chromosome, or did not pass basic alignment tests preventing us from correlating the
expression values of these reporters with a unique annotated human gene. The remaining 7214
(17%) reporters could be associated with either a unique gene or a unique intergenic location, but
could not be mapped to a transcript in RefSeq. The 7214 reporters are further partitioned into
three different levels of validity.
Conclusion: Expression array studies should evaluate the annotations of reporters and remove
those reporters that have suspect annotations. This evaluation can be done systematically and semi-
automatically, but one must recognize that data sources are frequently updated leading to slightly
changing validation results over time.
Background
Agilent-014850 Whole Human Genome Microarray 4 ×
44K G4112F consists of 43,376 oligonucleotides 60
nucleotides in length, most of which are annotated as cor-
responding to the sequence of a known or predicted
human gene, along with a number of probes that function
as controls. Agilent supplies an annotation file for the
array. The file provides the sequence of each oligonucle-
otide, its position on the NCBI human reference assem-
bly, and the gene and transcript putatively associated with
it. The annotation file states "This multi-pack (4 × 44K)
formatted microarray represents a compiled view of the
human genome as it is understood today." From here on,
we refer to each oligonucleotide as a "reporter", rather
than the more commonly used terms oligo, probe, or 60-
mer, to indicate that each oligonucleotide is supposed to
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"report" the expression of a single gene unambiguously.
Some reporters unambiguously distinguish between tran-
scripts of a single gene, but others hybridize with more
than one transcript of the same gene.
We sought to validate the annotations against the current
information for the human genome. Preliminary analysis
showed that a substantial number of reporter annotations
are questionable, and that other reporters may not be a
specific representation of a unique gene. Moreover, some
reporter annotations are incomplete and fail to provide a
discernible link between an oligonucleotide and a human
RNA. We therefore validated the reporter annotations
against the data present in the NCBI Entrez [1] database
http://www.ncbi.nlm.nih.gov. Because numerous report-
ers were annotated with an identifier from the Gene Index
Project but not recognized by Entrez, we used the Gene
Index Project [2] as an additional source of transcript data.
Entrez is a collection of related databases of biological
data, among which are the Entrez Nucleotide database of
biological sequences, the RefSeq [3] database providing
reference chromosome assemblies and transcribed
sequences for several species, and the Entrez Gene [4]
database cataloging known genes. Agilent includes the
RefSeq RNA identifier and Entrez Gene identifier as stand-
ard fields in the annotation file. The RefSeq identifier is,
however, supplied for only approximately two thirds of
the oligonucleotides on the chip.
The Entrez databases are frequently updated. As our
knowledge of the human genome increases, RNA and
gene records are added and edited. Unreliable records are
deleted or suppressed. Major changes to the data of a gene
merit a change in the identifier of the RefSeq RNAs, or
even of the Entrez Gene record. We therefore sought to
associate the oligonucleotides on the array with human
genes using the BLAST [5-7] and Splign [8] alignment
algorithms, and cross references between current database
records, rather than relying on the given identifiers. Since
Entrez databases have been updated multiple times after
the Agilent annotation file was prepared, some discrepan-
cies were expected. In concept, this study is similar to a
study performed by Gaj et al. [9] who evaluated the anno-
tations against protein databases, which do not include
the increasing number of non-protein coding genes. The
method and programs (which are freely available for
download; see Methods) used to perform this validation
should be applicable to other gene chips.
Results
We partitioned the reporters into five distinct categories of
descending confidence: fully valid; Refseq RNA valid;
other gene valid; possibly valid; and invalid. Lists of these
reporters, and where possible, the associated genes and
transcripts, are provided as additional files 1, 2, 3, 4 and
5. Counts of the number of reporters in each category are
shown in Table 1; for all tables, our results were tabulated
by chromosomes, but since we detected no chromosome-
specific effects, only genome-wide totals are shown. Fully
valid reporters can be associated with the transcripts of a
single gene and with chromosomal locations that lie
within the same gene. Refseq RNA valid reporters are asso-
ciated with the RefSeq RNA transcripts of a single gene,
but for one of the reasons described below cannot be
placed within the chromosomal extent of a single gene.
Other gene valid reporters can be placed on the chromo-
some within the location of a single gene, but the reporter
either lies in an intron of that gene or in a transcript not
yet in RefSeq. Possibly valid reporters can be placed at a
unique location on the human reference assembly, but
this location is not the position of a gene currently in Ent-
rez Gene. Despite the lack of solid evidence to associate a
possibly valid reporter to a gene, for studies relating
expression levels to genomic positions (e.g., reference
[10]), it makes sense to include these reporters. The divi-
sion into categories is dependent on the current contents
of the RefSeq and Entrez database, which are frequently
changing.
As explained in Methods, we restricted our analysis to the
42683 reporters labeled as being on an autosome or on
the X chromosome. We consider 25505 (60%) reporters
to be fully valid and associated with a single gene in Ref-
Seq. A fully valid reporter must have MegaBLAST align-
ments to the RefSeq RNA transcripts of exactly one gene in
Entrez Gene, and at least one of those alignments must be
high-quality as defined in Methods. An example of a
reporter that fails the uniqueness test is 1591a because it
has 100% identical matches to two related genes
PRAME16 and PRAME17. The alignment to a transcript
should be in the forward ("sense") direction; reporters
that have only alignments in the reverse direction are
invalid. If a reporter has alignments in the reverse direc-
tion, but also has at least one high-quality forward align-
Table 1: Reporters divided into the five categories discussed in Results
Fully Valid RefSeq RNA Valid Other Gene Valid Possibly Valid Invalid Total
25505 1859 2187 3168 9964 42683
The far right column shows the total number of eligible reporters, and the other entries show the total number of reporters in each category.BMC Genomics 2009, 10:566 http://www.biomedcentral.com/1471-2164/10/566
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ments to a RefSeq RNA whose status is more definite than
"model", then the reverse alignments are ignored and the
reporter remains under consideration for being fully valid
or RefSeq RNA valid. Table 2 summarizes the results of
aligning reporters to RefSeq RNA. The distinction between
fully valid and Refseq RNA valid is that fully valid report-
ers are placed by Splign on the reference assembly of chro-
mosome specified by Agilent and within the Entrez extent
of exactly one gene, which must be the same gene found
by alignment to RefSeq RNA. Fully valid reporters are per-
mitted to have additional alignments to their correspond-
ing gene, to the reverse complement of a different gene, to
intergenic regions, or to untranscribed pseudogenes.
There are 1859 (4%) reporters that align to the transcripts
of a single RefSeq gene, but that Splign did not place
within the accepted extent of exactly one gene. We do not
consider such reporters to be fully valid, but rather place
them in the category of "Refseq RNA valid." Reporters in
this category fall into four distinct classes (Table 3). The
first class consists of reporters not placed within the
accepted extent of any gene. For example, ID 22872b is
supposed to match gene SLC35D1, but maps approxi-
mately 3.6 kbp away from the RefSeq extent of SLC35D1.
The second class includes reporters placed within the
extent of more than one gene. The additional alignments
may be to introns, or may instead be parts of transcripts
not yet included in the RefSeq RNA database. The third
class includes reporters that are placed at a single location
on the reference assembly, but this position lies within the
extent of more than one gene because the genes them-
selves overlap. For example, reporter 5099c matches gene
KTI12, which lies in an intron of another gene TXNDC12.
We consider it likely that reporters in this third class iden-
tify the transcripts of a single gene, but to avoid potential
confusion we do not include these reporters in the list of
those that are fully valid. The fourth class consists of
reporters that align to a different gene than the one found
by aligning to RNA transcripts. We did not need to con-
sider the class of genes on chromosome X that are dupli-
cated on the Y chromosome; no reporters mapped to the
positions of these genes.
We do not require that the GeneID associated with a
reporter during the validation process matches the
GeneID supplied by Agilent, nor that the chromosomal
positions match exactly. GeneIDs may differ because the
Entrez and RefSeq databases are not static, and sometimes
updates to records merit changes in an identifier. The
positions found by Splign sometimes disagree with the
positions supplied by Agilent because a splice site occurs
within the alignment, and Splign resolves the splice differ-
ently. There are also 87 reporters that are fully valid, but
align to more than one position within their identified
gene.
Excluding the 27364 (64%) fully valid and Refseq RNA
valid reporters leaves 15319 (36%) reporters. Among
those, 4472 were found to be invalid by the tests of align-
ment to Refseq RNA (Table 2: sum reverse complement +
multiple genes), leaving 10847 reporters for further eval-
uation. We were able to associate 7603 of these with a
putative transcript included in Entrez Nucleotide or the
Gene Index Database [1] using the identifier provided in
the annotation file; the remaining 3244 (10847 - 7603)
reporters were considered invalid and were excluded from
further consideration by rules described in Methods (see
Table 4).
We used Splign to place the remaining 7603 reporters on
the human reference assembly. Table 5 summarizes the
results of performing this placement. Of the 7603 report-
ers, 2187 are placed within the extent of exactly one gene,
and this gene is on the chromosome specified in the anno-
tation file. We refer to these reporters as "other gene
valid". Reporters that also align to the reverse comple-
ment of a gene are not included in this category, because
we do not have sufficient evidence to suggest that the for-
ward copy, rather than the reverse, is transcribed. Moreo-
ver, 3168 of the 7608 reporters may be placed at a single
position on the reference assembly, though this position
is not the location of a known gene. We categorize these
reporters as "possibly valid" (Column 5, table: 1). Any
secondary placement of a reporter suffices to exclude it
from this category, because Entrez Gene does not provide
sufficient evidence to determine which unit of transcrip-
tion, if any, the reporter measures.
Table 2: Results of aligning all eligible reporters to the database of human RefSeq RNAs
Eligible Rev. Comp. Multiple Genes Unique Gene No Alignment
42683 2009 2463 27364 10847
The first column show the total number of eligible reporters. The second column shows the number of reporters eliminated because they align to 
the reverse complement of a RefSeq RNA. The third column shows the number of reporters eliminated because they align to the transcripts of 
more than one gene. The fourth column lists the number of reporters that align to the transcripts of a single gene. The fifth column shows the 
number of reporters that did not have a sufficiently high-scoring alignment to a RefSeq RNA. Reporters that could be counted in more than one 
column of the third through fifth columns are counted in the leftmost column.BMC Genomics 2009, 10:566 http://www.biomedcentral.com/1471-2164/10/566
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Discussion
We initiated a study to re-evaluate published expression
data that were suspicious because they suggested that
some mouse genes hybridized better to the Agilent 4 × 44
chip than the orthologous human gene, even though the
chip is designed to hybridize to human genes [10]. Pre-
liminary sequence analysis showed that some of the
reporters did not align to any known human RNA, and
others aligned only to reverse complements. Therefore, we
decided to check the annotation file reporter by reporter.
To our surprise, approximately 23% of the reporters failed
basic tests and could not be assigned any meaning. Thus,
the signal intensities of these reporters, which we call
"invalid", do not provide useful information as to the
expression level of a specific gene. While we had expected
some reporters to be problematic - perhaps 5-10% - due
to updates to information about the human genome, we
d i d  n o t ,  h o w e v e r ,  e x p e c t  t h a t  a s  m u c h  a s  4 0 %  o f  t h e
reporters on a 44K gene expression array would for one
reason or another yield uninterpretable data. The distinc-
tion between 40% uninterpretable and the earlier 23%
includes reporters that map uniquely to the human
genome but not to a region covered by a RefSeq transcript;
for example, this includes reporters that map to an intron.
A search with PubMed and Google found that numerous
studies have used Agilent 4 × 44K human expression
chips; we cite 10 examples from different research groups
[11-20]. Each paper has a small subsection in Methods
explaining how the 4 × 44 arrays were hybridized and
how the data were analyzed. None of these 10 studies
seems to have considered the possibility that the annota-
tions provided do not correspond unambiguously to
human genes. The Methods in two studies [12,13]
describe some steps to restrict analysis to those reporters
for which the Agilent annotation includes a human gene
symbol. Another study [19] used a pre-established list of
genes, but does not explain how gene identifiers were
matched to the annotation file. The lack of a gene symbol
in the annotation file eliminates 6089 of the 9964 report-
ers we consider invalid, and also eliminates 799 of the
25505 fully valid reporters, 148 of the 1859 Refseq RNA
valid reporters, 1273 of the 2187 other gene valid report-
ers, and 2470 of 3168 possibly valid reporters. Of the
31904 reporters with a gene symbol, we consider 24706
(77%) fully valid. Our validation of the annotated tran-
script identifier invalidates fewer reporters than a test for
the presence of a gene symbol, and would not, by itself, be
an effective filter. An example of a fully valid reporter that
is not annotated with a gene symbol or the identifier of a
transcript is reporter ID 27386, which aligns perfectly to
transcripts of the gene RPP14 (GeneID:11102).
Standards for microarray experiments, such as MIAME
[21], are evolving. Generally, these standards seek to
ensure that the experiments and data analysis are suffi-
ciently detailed so as to be reproduced at another site. The
MIAME paper [21] does recognize the potential for anno-
tation problems, stating, for example, that "Because refer-
ences to an external gene index may not be stable, it is
essential to physically identify each element's composi-
tion. Disclosing the nature of the relationship between an
array element and its cognate gene's transcript allows
informed assessment..." However, there seems to be no
easy-to-enforce mechanism to ensure that the annotations
that come with an expression array are internally consist-
ent, let alone consistent with changing external genomic
databases. So long as researches follow MIAME and
deposit data in detail, it is possible to apply reporter vali-
dation post-facto.
Table 3: Results of placing the reporters that align with the RefSeq RNA transcripts of a single gene on the chromosome
Eligible Fully Valid No Placement Multiple Genes Overlapping Genes Wrong Gene
27364 25505 177 1429 238 15
The first column is the total number of eligible reporters, which is the same data as the fourth column of Table 2. The second column shows the 
number of reporters that have a valid placement in a unique gene; this is the same data as the first column of Table 1. The third column shows the 
number of reporters that did not have a high-quality placement. The fourth column shows the number of reporters that have multiple placements 
and are placed in the location of more than one gene. The fifth column shows the number of reporters with a single placement, but a placement 
within overlapping genes. The sixth column shows the number of reporters placed in a single gene, but not the same gene as found by alignment to 
RNA. The sum of the four rightmost columns gives the 2565 RNA valid reporters in Table 1.
Table 4: Counts of reporters associated with a putative 
transcript not in RefSeq
Eligible NoID Suppressed No Alignment Valid ID
10847 2114 845 285 7603
The first column shows the number of reporters that did not have an 
alignment with a RefSeq RNA; these data are also shown as the fifth 
column of Table 2. The second column shows the number of 
reporters that had no discernible identifier in the annotation file. The 
third column shows the number of reporters for which the annotated 
identifier had been suppressed or removed in Entrez Nucleotide. The 
fourth column shows the number of reporters that did not align with 
the annotated sequence. The fifth column shows the number of 
reporters that could be associated with a putative transcript. 
Reporters that could be counted in more than one of the second 
through fourth columns are counted in the leftmost column.BMC Genomics 2009, 10:566 http://www.biomedcentral.com/1471-2164/10/566
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Conclusion
We hope that our reporter-by-reporter validation of the 4
× 44K array annotations will prove useful for labs using
these chips. Our recommendations are the following:
1. It is safe to use the 25505 fully valid reporters.
2. It is unsafe to use the 9964 invalid reporters.
3. The 4046 reporters that are either Refseq RNA valid
or other gene valid might be used for gene-based stud-
ies.
4. The 7214 reporters that are in any of the three inter-
mediate categories (Refseq RNA valid, other gene
valid, possibly valid) might be used for position-based
studies.
5. In any study that uses reporters in the three interme-
diate categories and reports either genome-wide or
chromosome-wide results, the analysis should be
repeated with the fully valid reporters only to verify
that this more reliable subset provides qualitatively
identical results.
Methods
The software we developed for this study is available at
ftp://ftp.ncbi.nlm.nih.gov/pub/microarray_pipeline.
Because some of the data sources change over time, read-
ers may wish to rerun the analysis. Alternatively, readers
may wish to modify the software to analyze other micro-
array annotation files.
Databases
We validated reporter annotations using the data current
in Entrez on September 29, 2009. On this date, the current
reference assembly was build 37.1, and the version
number of RefSeq was 37. Each transcript in RefSeq is
linked with an Entrez Gene database identifier (GeneID).
Thus, given a RefSeq transcript, it is possible to find its
GeneID. Conversely, for any human GeneID, one may
determine the list of all transcripts for that gene that
appear in RefSeq. The Entrez Gene database is the direct
successor of the LOCUSLINK database, which is men-
tioned in the Agilent annotation file. The two databases
use the same identifiers.
We retrieved transcript data from the Gene Index Data-
base on May 29, 2009. On this date, the release number
for the human genome was 17.0. We performed a batch
retrieval using the web interface http://compbio.dfci.har
vard.edu/tgi.
Microarray Annotation File
We analyzed the oligonucleotides on the Agilent-014850
Whole Human Genome Microarray 4 × 44K G4112F. Agi-
lent provides an annotation file, putatively associating
reporters with expressed human RNAs, and these RNAs
with their respective genes. Agilent sometimes releases
updated versions of the annotation file. We used a version
from late 2007 that was used in a previous study [10]. The
latest version of the annotation file, released April 16,
2009, gives nearly identical results for fully valid and Ref-
Seq RNA valid reporters; the only differences arise for a
few reporters that have been assigned a different chromo-
some in the newer annotation file. Using the newest
annotation file does not qualitatively change the results
for the other gene valid, possibly valid, or invalid markers.
Of the 43,376 non-control oligonucleotides on the array,
414 had no chromosome labeled, 20 were associated with
the mitochondrial genome, 133 were associated with the
Y chromosome, and 126 were labeled with the qualifier
"random". We did not consider any of these reporters,
choosing instead to focus on the 42,683 reporters associ-
ated with the autosomes and the X chromosome.
Aligning Nucleotide Sequences
Except where otherwise stated, we aligned nucleotide
sequences using NCBI's MegaBLAST program, version
2.2.21, with default settings. MegaBLAST is optimized for
nearly identical sequences. By default, MegaBLAST filters
the query sequence to exclude low-complexity regions.
Thus, it may find no alignments for some reporters that
Table 5: Results of placing the reporters that do not align with a RefSeq RNA transcript
Eligible No Placement Multiple Genes Overlapping Genes Wrong Chromosome Other Gene Valid Possibly Valid
7603 1662 389 91 83 2187 3168
The first column is the total number of eligible reporters, which is the same data as the fifth column of Table 4. The second column shows the 
number of reporters that could not be placed. The third column shows the number of reporters that have multiple placements and are placed in 
the location of more than one gene. The fourth column shows the number of reporters with a single placement, but a placement within overlapping 
genes. The fifth column shows the number of reporters with a unique placement on an unexpected chromosome. The sixth column shows the 
number of reporters that could be associated with a unique gene and thus are considered positionally valid. The seventh column shows the number 
of reporters that could be associated with a unique placement, not on a gene. The sixth and seventh columns of this table are the same as the third 
and fourth columns of Table 1. Reporters that could be counted in more than one column of the second through fifth columns are counted in the 
leftmost column.BMC Genomics 2009, 10:566 http://www.biomedcentral.com/1471-2164/10/566
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contain repetitive DNA. The use of this option is appropri-
ate, as we have low confidence that repetitive DNA may be
used to identify a unique gene.
MegaBLAST has an option "-S" that causes it to search a
database of nucleotide sequences using the query only in
the forward sense, or only in the reverse complement
sense. We use this option as appropriate without further
comment.
Aligning Reporters with RefSeq Human Transcripts
We define that an oligonucleotide aligns with a human
RNA transcript if MegaBLAST [8] with default parameters
reports such an alignment. By default, MegaBLAST finds
alignments between two sequences only if, after the query
has been filtered to mask low-complexity sequences, the
sequences still have a gapless alignment of length at least
28, sometimes relaxed to length 16. The alignment ulti-
mately reported by MegaBLAST may be a higher-scoring
alignment with gaps.
To confirm the association of a reporter with a gene, we
require that the alignment have a score of at least 100 bits;
we refer to such alignments as high quality alignments.
With the command-line MegaBLAST's default scoring sys-
tem, a perfect alignment has a score of 119 bits; the web-
enabled version uses a different default scoring system.
Each mismatch in a full length alignment reduces the
score by approximately eight bits, whereas each mismatch
at the end of an oligonucleotide reduces the score by
approximately two bits. Figure 1 shows a flowchart of the
process used to validate a reporter through alignment to
RefSeq RNAs.
Comparing Reporters to their Annotated Sequence
We collected the set of reporters that were not validated
and eliminated by alignment to a RefSeq human gene
transcript. For each of these reporters, we searched field 15
of the annotation file for a sequence identifier. We pre-
ferred, in order, a RefSeq identifier, a GenBank [22] acces-
sion number, or an identifier from the Gene Index Project.
GenBank accession numbers can be used to retrieve
records from Entrez Nucleotide. The type of identifier was
determined by the format. RefSeq identifiers start with the
string "ref"; GenBank identifiers start with "gb"; and iden-
tifiers from the Gene Index Project start with "thc". We
retrieved the sequences putatively associated with each
reporter by the annotation file from either Entrez Nucle-
otide or from the Gene Index Project. At this stage, we
eliminated reporters for which no identifiable transcript
identifier could be found in the annotation file, or for
which the identified sequence could not be found in
either database. If the sequence was annotated within Ent-
rez Nucleotide as replaced or suppressed, we excluded the
corresponding reporter from further consideration.
We used MegaBLAST to align each candidate reporter with
its annotated sequence. MegaBLAST's parameters were
relaxed to use a word size of 16 and to omit low-complex-
ity filtering, but an alignment was still required to have a
score of at least 100 to be considered a significant match.
Those reporters that had no significant match to their
annotated sequence were eliminated from further consid-
eration. For example, reporter 5467d is supposed to match
NM_182578; the oligo does align to an obsolete version
NM_182578.1, but not to the current version
NM_182578.2. Therefore, 5467 was excluded.
Validating Reporters by Placement on the Reference 
Assembly
We used Splign to place candidate reporters on the assem-
bled chromosomes of the human reference assembly. We
aligned reporters to chromosomes using MegaBLAST with
word size 16, but otherwise used default parameters. We
used the resulting alignments as input to Splign, which
takes splice sites into consideration when placing report-
Flowchart showing the process, described in Methods, used  to include a reporter in one of the top two categories, invali- dated, or declare it eligible for validation for position Figure 1
Flowchart showing the process, described in Meth-
ods, used to include a reporter in one of the top two 
categories, invalidated, or declare it eligible for vali-
dation for position. The process for validating by position 
is shown in Figure 2.
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ers. We say a reporter is placed at a location on a chromo-
some if this combination of MegaBLAST with Splign
reports such a placement, and at least 40 of 60 bases in the
oligonucleotide match the chromosomal sequence. A
placement that matches at least 50 of the 60 is considered
a high-quality alignment. For each placement on a chro-
mosome, we found the entry in Entrez Gene, if any, that
intersects with that position. If the gene was assigned a
position in MapViewer [2], then we used that position.
Otherwise, we took the union of all the RefSeq transcripts
for the gene to determine the widest possible extent. Fig-
ures 1 and 2 show flowcharts of the process used to vali-
date reporters by placement on the reference assembly.
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Appendix - Oligonucleotide Sequences
aCCTCAAGAACCCCTTGGGAACCTTTATATTCTGTCAT-
GCTTACCTAGCTGATCAGGACAT
bAACAGGACTCTGTGTCTCATTGCCTCTAGAATCCT-
TAGGTAGCAGTTTCTGTTCACTGTC
cGAATTGTTTTAAAACAATTGTGAACAGAAACTGAAGAT-
GGTACAGTTCTACATCTGCACC
dTATCACGCTCCTCCCACACCCACCCTGGCTTCCAT-
CATGAGTGCAGTGTCATCTCAGCGG
Additional material
Additional file 1
List of fully valid reporters, supplied as a tab delimited text file with 
CR LF line endings. The columns of the file represent 1) the identifier 
supplied in the first column of the Agilent annotation file; 2) the Entrez 
Gene identifier of the corresponding gene; 3) the chromosome matched by 
the reporter; 4) the start position of the placement of the reporter on build 
36 of the NCBI reference assembly; 5) the end position of the placement 
of the reporter; 6) the orientation of the placement of the reporter; and 7) 
a semicolon delimited list of RefSeq transcripts matched by the reporter. 
Some reporters are placed at more than one location within the gene; for 
these, the start and end positions are marked with an asterisk.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-566-S1.TXT]
Additional file 2
List of Refseq RNA valid reporters. The format is similar to the format 
of additional file 1, except chromosomal positions are not supplied.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-566-S2.TXT]
Additional file 3
List of reporters classified as "other gene valid." The format is similar 
to the format of additional file 1, except transcript identifiers are not pro-
vided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-566-S3.TXT]
Additional file 4
List of reporters classified as "possibly valid." The format is similar to the 
format of additional file 1, except gene and transcript identifiers are not 
provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-566-S4.TXT]
Flowchart showing the process, described in Methods, used  to validate a reporter by position, placing it into one of the  categories: other gene valid, possibly valid, or invalid Figure 2
Flowchart showing the process, described in Meth-
ods, used to validate a reporter by position, placing it 
into one of the categories: other gene valid, possibly 
valid, or invalid.
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